Osaic Holdings’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $619 | Hold |
680
| – | – | ﹤0.01% | 6794 |
|
|
2025
Q1 | $618 | Buy |
680
+300
| +79% | +$273 | ﹤0.01% | 6788 |
|
|
2024
Q4 | $414 | Hold |
380
| – | – | ﹤0.01% | 6887 |
|
|
2024
Q3 | $288 | Hold |
380
| – | – | ﹤0.01% | 6894 |
|
|
2024
Q2 | $471 | Hold |
380
| – | – | ﹤0.01% | 6797 |
|
|
2024
Q1 | $718 | Buy |
380
+318
| +513% | +$601 | ﹤0.01% | 6571 |
|
|
2023
Q4 | $164 | Hold |
62
| – | – | ﹤0.01% | 6905 |
|
|
2023
Q3 | $143 | Hold |
62
| – | – | ﹤0.01% | 7017 |
|
|
2023
Q2 | $273 | Hold |
62
| – | – | ﹤0.01% | 7002 |
|
|
2023
Q1 | $202 | Sell |
62
-2,000
| -97% | -$6.52K | ﹤0.01% | 7127 |
|
|
2022
Q4 | $6K | Sell |
2,062
-46,200
| -96% | -$134K | ﹤0.01% | 6156 |
|
|
2022
Q3 | $107K | Buy |
48,262
+9,500
| +25% | +$21.1K | ﹤0.01% | 4301 |
|
|
2022
Q2 | $96K | Buy |
38,762
+580
| +2% | +$1.44K | ﹤0.01% | 4450 |
|
|
2022
Q1 | $2.41M | Buy |
38,182
+11,562
| +43% | +$729K | ﹤0.01% | 1781 |
|
|
2021
Q4 | $301K | Sell |
26,620
-4,600
| -15% | -$52K | ﹤0.01% | 3562 |
|
|
2021
Q3 | $455K | Buy |
31,220
+10,800
| +53% | +$157K | ﹤0.01% | 3122 |
|
|
2021
Q2 | $237K | Buy |
20,420
+4,000
| +24% | +$46.4K | ﹤0.01% | 3723 |
|
|
2021
Q1 | $200K | Buy |
16,420
+16,300
| +13,583% | +$199K | ﹤0.01% | 3729 |
|
|
2020
Q4 | $2K | Hold |
120
| – | – | ﹤0.01% | 5963 |
|
|
2020
Q3 | $2K | Hold |
120
| – | – | ﹤0.01% | 5767 |
|
|
2020
Q2 | $3K | Hold |
120
| – | – | ﹤0.01% | 5579 |
|
|
2020
Q1 | $2K | Buy |
+120
| New | +$2K | ﹤0.01% | 5571 |
|